Clinical Trial Update: Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Study [Phase 2]

View source ↗

Summary

A Phase 2 single-arm prospective study evaluating Fruquintinib with PD-1 inhibitors as first-line maintenance therapy for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Wu Jun | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN